Annual FCF
-$32.83 M
+$28.64 M+46.59%
December 31, 2022
Summary
- As of February 10, 2025, SELB annual free cash flow is -$32.83 million, with the most recent change of +$28.64 million (+46.59%) on December 31, 2022.
- During the last 3 years, SELB annual FCF has risen by +$18.65 million (+36.23%).
Performance
SELB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$9.21 M
+$692.00 K+6.98%
September 30, 2023
Summary
- As of February 10, 2025, SELB quarterly free cash flow is -$9.21 million, with the most recent change of +$692.00 thousand (+6.98%) on September 30, 2023.
- Over the past year, SELB quarterly FCF has dropped by -$13.13 million (-335.26%).
Performance
SELB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$40.08 M
-$13.13 M-48.74%
September 30, 2023
Summary
- As of February 10, 2025, SELB TTM free cash flow is -$40.08 million, with the most recent change of -$13.13 million (-48.74%) on September 30, 2023.
- Over the past year, SELB TTM FCF has increased by +$12.43 million (+23.68%).
Performance
SELB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SELB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.6% | -335.3% | +23.7% |
| 3 y3 years | +36.2% | -114.1% | -240.2% |
| 5 y5 years | +37.8% | +42.7% | +22.1% |
SELB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.2% | -335.3% | +244.4% | +48.7% | +68.0% |
| 5 y | 5-year | -196.4% | +87.2% | -114.1% | +244.4% | -202.5% | +68.0% |
| alltime | all time | -196.4% | +87.2% | -114.1% | +244.4% | -202.5% | +68.0% |
Selecta Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.21 M(-7.0%) | -$40.08 M(+48.7%) |
| Jun 2023 | - | -$9.91 M(+11.4%) | -$26.95 M(-8.4%) |
| Mar 2023 | - | -$8.89 M(-26.2%) | -$29.41 M(-10.4%) |
| Dec 2022 | -$32.83 M(-46.6%) | -$12.06 M(-407.9%) | -$32.83 M(-37.5%) |
| Sep 2022 | - | $3.92 M(-131.7%) | -$52.51 M(-22.0%) |
| Jun 2022 | - | -$12.37 M(+0.4%) | -$67.34 M(+9.3%) |
| Mar 2022 | - | -$12.32 M(-61.2%) | -$61.63 M(+0.3%) |
| Dec 2021 | -$61.47 M(-280.4%) | -$31.74 M(+190.9%) | -$61.47 M(+65.4%) |
| Sep 2021 | - | -$10.91 M(+63.8%) | -$37.17 M(-195.1%) |
| Jun 2021 | - | -$6.66 M(-45.2%) | $39.09 M(+15.8%) |
| Mar 2021 | - | -$12.16 M(+63.4%) | $33.74 M(-1.0%) |
| Dec 2020 | $34.07 M(-166.2%) | -$7.44 M(-111.4%) | $34.07 M(+19.1%) |
| Sep 2020 | - | $65.35 M(-644.2%) | $28.59 M(-159.7%) |
| Jun 2020 | - | -$12.01 M(+1.5%) | -$47.88 M(+11.2%) |
| Mar 2020 | - | -$11.83 M(-8.4%) | -$43.08 M(-16.3%) |
| Dec 2019 | -$51.48 M | -$12.91 M(+16.1%) | -$51.48 M(-0.4%) |
| Sep 2019 | - | -$11.13 M(+54.5%) | -$51.69 M(-8.8%) |
| Jun 2019 | - | -$7.20 M(-64.4%) | -$56.65 M(-15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$20.24 M(+54.3%) | -$66.68 M(+11.1%) |
| Dec 2018 | -$60.05 M(+13.8%) | -$13.12 M(-18.5%) | -$60.05 M(+0.5%) |
| Sep 2018 | - | -$16.09 M(-6.6%) | -$59.74 M(+0.9%) |
| Jun 2018 | - | -$17.24 M(+26.7%) | -$59.21 M(+16.1%) |
| Mar 2018 | - | -$13.60 M(+6.2%) | -$50.99 M(-3.4%) |
| Dec 2017 | -$52.76 M(+159.3%) | -$12.81 M(-17.7%) | -$52.76 M(+36.8%) |
| Sep 2017 | - | -$15.56 M(+72.6%) | -$38.58 M(+34.1%) |
| Jun 2017 | - | -$9.02 M(-41.4%) | -$28.76 M(+13.2%) |
| Mar 2017 | - | -$15.37 M(-1218.9%) | -$25.41 M(+24.9%) |
| Dec 2016 | -$20.34 M(-13.9%) | $1.37 M(-123.9%) | -$20.34 M(-31.0%) |
| Sep 2016 | - | -$5.74 M(+1.3%) | -$29.49 M(-1.2%) |
| Jun 2016 | - | -$5.67 M(-45.0%) | -$29.84 M(+3.2%) |
| Mar 2016 | - | -$10.31 M(+32.6%) | -$28.91 M(+22.4%) |
| Dec 2015 | -$23.63 M(+83.0%) | -$7.77 M(+27.6%) | -$23.63 M(+49.0%) |
| Sep 2015 | - | -$6.09 M(+28.4%) | -$15.85 M(+62.4%) |
| Jun 2015 | - | -$4.74 M(-5.5%) | -$9.76 M(+94.5%) |
| Mar 2015 | - | -$5.02 M | -$5.02 M |
| Dec 2014 | -$12.91 M | - | - |
FAQ
- What is Selecta Biosciences annual free cash flow?
- What is the all time high annual FCF for Selecta Biosciences?
- What is Selecta Biosciences annual FCF year-on-year change?
- What is Selecta Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Selecta Biosciences?
- What is Selecta Biosciences quarterly FCF year-on-year change?
- What is Selecta Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Selecta Biosciences?
- What is Selecta Biosciences TTM FCF year-on-year change?
What is Selecta Biosciences annual free cash flow?
The current annual FCF of SELB is -$32.83 M
What is the all time high annual FCF for Selecta Biosciences?
Selecta Biosciences all-time high annual free cash flow is $34.07 M
What is Selecta Biosciences annual FCF year-on-year change?
Over the past year, SELB annual free cash flow has changed by +$28.64 M (+46.59%)
What is Selecta Biosciences quarterly free cash flow?
The current quarterly FCF of SELB is -$9.21 M
What is the all time high quarterly FCF for Selecta Biosciences?
Selecta Biosciences all-time high quarterly free cash flow is $65.35 M
What is Selecta Biosciences quarterly FCF year-on-year change?
Over the past year, SELB quarterly free cash flow has changed by -$13.13 M (-335.26%)
What is Selecta Biosciences TTM free cash flow?
The current TTM FCF of SELB is -$40.08 M
What is the all time high TTM FCF for Selecta Biosciences?
Selecta Biosciences all-time high TTM free cash flow is $39.09 M
What is Selecta Biosciences TTM FCF year-on-year change?
Over the past year, SELB TTM free cash flow has changed by +$12.43 M (+23.68%)